Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria.

Ítems similars

• Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts.
  per: Van der Auwera, P, et al.
  Publicat: (1991)
• Bactericidal activity and killing rate of serum in volunteers receiving teicoplanin alone or in combination with oral or intravenous rifampin.
  per: Van der Auwera, P, et al.
  Publicat: (1987)
• Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections.
  per: Van der Auwera, P, et al.
  Publicat: (1985)
• Moxalactam treatment of anaerobic infections in cancer patients.
  per: Lagast, H, et al.
  Publicat: (1982)
• Serum bactericidal activity and killing rate for volunteers receiving imipenem, imipenem plus amikacin, and ceftazidime plus amikacin against Pseudomonas aeruginosa.
  per: Van der Auwera, P, et al.
  Publicat: (1986)